期刊
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
卷 53, 期 5, 页码 781-791出版社
WALTER DE GRUYTER GMBH
DOI: 10.1515/cclm-2014-0746
关键词
antibiotics; 2D-UHPLC; serum concentration; therapeutic drug monitoring; ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS)
资金
- Merieux Research Grant (Institut Merieux, Lyon, France)
Background: Recent studies have demonstrated highly variable blood concentrations of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in critically ill patients with a high incidence of sub-therapeutic levels. Consequently, therapeutic drug monitoring (TDM) of these antibiotics has to be considered, requiring robust and reliable routine analytical methods. The aim of the present work was to develop and validate a multi-analyte ultra high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) method for the simultaneous quantification of the above mentioned antibiotics. Methods: Sample preparation included a manual protein precipitation step followed by two-dimensional ultra high performance liquid chromatography (2D-UHPLC). Corresponding stable isotope-labeled substances were used as internal standards for all of the analytes, with the exception of tazobactam. The injected sample volume was 7 mu L. The run time was 5.0 min. Results: Inaccuracy was <= 8% and imprecision coefficient of variation (CV) was < 9% for all analytes. Only minor matrix effects and negligible carry-over was observed. The method was found to be robust during the validation period. Conclusions: We were able to develop a reliable 2D-UHPLCMS/MS method addressing analytes with highly heterogeneous physico-chemical properties. The novel assay may be an efficient tool for an optimized process workflow in clinical laboratories for important antibiotics in regards to TDM.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据